PD
CERE

Point72 (DIFC)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Point72 (DIFC)’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,089
Closed -$331K – 1948
2024
Q2 		$331K Buy
+8,089
New +$337K 0.01% 749

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Point72 (DIFC)'s CERE Position: Q3 2024 in Review

Point72 (DIFC) sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 8,089 shares — an estimated $331K sold.

Point72 (DIFC) first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $331K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Point72 (DIFC) reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Point72 (DIFC) sold 8,089 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $331K.
  • Point72 (DIFC) first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Point72 (DIFC)'s Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $331K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Point72 (DIFC)'s 13F filing for Q3 2024, filed 14 Nov 2024.